WebWARNING: DO NOT INTERCHANGE WITH OTHER DAUNORUBICIN AND/OR CYTARABINE-CONTAINING PRODUCTS See full prescribing information for complete boxed warning. • VYXEOS has different dosage recommendations than daunorubicin hydrochloride injection, cytarabine injection, daunorubicin citrate liposome injection, and … WebAs an antineoplastic agent, daunorubicin carries significant toxicities including cytopenias, hepatotoxicity, and extravasation reactions. Like other anthracyclines, daunorubicin also exhibits cardiotoxicity in proportion with the cumulative dose received over time. Mechanism of …
Doxorubicin Side Effects Dosage Precautions Warnings
WebJan 1, 2024 · Daunorubicin hydrochloride injection is contraindicated in patients who have shown a hypersensitivity to it. WARNINGS Bone Marrow Daunorubicin hydrochloride is a potent bone marrow suppressant. Suppression will occur in all patients given a therapeutic dose of this drug. You should not use daunorubicin if you are allergic to it. Tell your doctor if you have ever had: 1. heart disease; 2. kidney disease; 3. liver disease; 4. a weak immune system (caused by disease or by using certain medicines); or 5. if you have ever been treated with doxorubicin, epirubicin, idarubicin, … See more Daunorubicin is used in combination chemotherapy to treat leukemia. Daunorubicin may also be used for purposes not listed in this medication guide. See more Since this medication is given by a healthcare professional in a medical setting, an overdose is unlikely to occur. See more Daunorubicin may cause dangerous effects on your heart, and can also increase your risk of bleeding or infection. Call your doctor at … See more Daunorubicin is given as an infusion into a vein. A healthcare provider will give you this injection. Before you receive each dose of daunorubicin, your heart function may need to be checked with an electrocardiograph or … See more small rosetti crossbody purses
cytarabine/daunorubicin liposomal (Rx) - Medscape
WebCERUBIDINE (Daunorubicin HCl) FOR INJECTION Rx ONLY WARNING 1. Cerubidine must be given into a rapidly flowing intravenous infusion. It must neverbe given by the intramuscular or subcutaneous route. Severe local tis-sue necrosis will occur if there is extravasation during administration. 2. Myocardial toxicity manifested in its most severe … WebTriad of back pain, flushing, and chest tightness reported in patients receiving liposomal daunorubicin citrate; generally occurs during first 5 minutes of infusion, subsides with infusion interruption, and generally does not recur if infusion resumed at slower rate. (See Infusion-related Effects under Cautions.) Introduction WebAs an antineoplastic agent, daunorubicin carries significant toxicities including cytopenias, hepatotoxicity, and extravasation reactions. Like other anthracyclines, daunorubicin … small rotary cutter